Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387675354> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W4387675354 abstract "The approved standard dose of pembrolizumab (200 mg administrated every 3 weeks) for cancer treatment imposes a significant financial burden on patients. However, no study has analyzed the clinical outcomes of low-dose pembrolizumab among individuals diagnosed with gynecologic cancer. The primary objective of this study was to assess the effectiveness and safety of a low-dose pembrolizumab regimen in real-world clinical practice. We retrospectively assessed the efficacy and safety data of patients with gynecologic malignancies who received pembrolizumab between 2017 and 2022 at Kaohsiung Chang Gung Memorial Hospital. Furthermore, we conducted a comparative analysis of the objective response rate (ORR) and progression-free survival (PFS) between patients with deficient mismatch repair (dMMR) and proficient MMR (pMMR). A total of thirty-nine patients were included and received pembrolizumab at fixed dosages of 50 mg (5.1%), 100 mg (84.6%) and 200 mg (10.3%) per cycle. Compared to the pMMR group, the dMMR group exhibited a tendency toward improved ORR (45.5% vs. 13.0%, p = 0.074), and notably, the median duration of response remained unreached. There was no significant difference in PFS between the dMMR and pMMR groups; however, the patients with dMMR in tumor tissue had a trend of better survival (p = 0.079). Incidence of immune-related adverse events (irAEs) of any grade was observed in 13 patients (33.3%), with 3 individuals (7.7%) experiencing grade 3 or 4 events. Low-dose pembrolizumab may be a cost-effective and safe treatment option without compromising clinical outcomes in patients with refractory gynecologic cancers." @default.
- W4387675354 created "2023-10-17" @default.
- W4387675354 creator A5013129858 @default.
- W4387675354 creator A5015703643 @default.
- W4387675354 creator A5037659796 @default.
- W4387675354 creator A5040116367 @default.
- W4387675354 creator A5047715323 @default.
- W4387675354 creator A5048749599 @default.
- W4387675354 creator A5076626440 @default.
- W4387675354 date "2023-10-01" @default.
- W4387675354 modified "2023-10-18" @default.
- W4387675354 title "Real-world efficacy and safety of low-dose pembrolizumab in patients with advanced and refractory gynecologic cancers" @default.
- W4387675354 cites W1940241680 @default.
- W4387675354 cites W1982488143 @default.
- W4387675354 cites W1990675339 @default.
- W4387675354 cites W2041440766 @default.
- W4387675354 cites W2049553585 @default.
- W4387675354 cites W2112196468 @default.
- W4387675354 cites W2133075384 @default.
- W4387675354 cites W2136859769 @default.
- W4387675354 cites W2150048477 @default.
- W4387675354 cites W2342029300 @default.
- W4387675354 cites W2342481353 @default.
- W4387675354 cites W2554618897 @default.
- W4387675354 cites W2612703804 @default.
- W4387675354 cites W2620733650 @default.
- W4387675354 cites W2621194109 @default.
- W4387675354 cites W2622499649 @default.
- W4387675354 cites W2753432434 @default.
- W4387675354 cites W2887577080 @default.
- W4387675354 cites W2923110060 @default.
- W4387675354 cites W2984359187 @default.
- W4387675354 cites W3027862477 @default.
- W4387675354 cites W3049327094 @default.
- W4387675354 cites W3087780810 @default.
- W4387675354 cites W3125723584 @default.
- W4387675354 cites W3193344670 @default.
- W4387675354 cites W3200231835 @default.
- W4387675354 cites W4206041598 @default.
- W4387675354 cites W4213455475 @default.
- W4387675354 cites W4280643703 @default.
- W4387675354 cites W4310121347 @default.
- W4387675354 doi "https://doi.org/10.1016/j.jfma.2023.09.020" @default.
- W4387675354 hasPublicationYear "2023" @default.
- W4387675354 type Work @default.
- W4387675354 citedByCount "0" @default.
- W4387675354 crossrefType "journal-article" @default.
- W4387675354 hasAuthorship W4387675354A5013129858 @default.
- W4387675354 hasAuthorship W4387675354A5015703643 @default.
- W4387675354 hasAuthorship W4387675354A5037659796 @default.
- W4387675354 hasAuthorship W4387675354A5040116367 @default.
- W4387675354 hasAuthorship W4387675354A5047715323 @default.
- W4387675354 hasAuthorship W4387675354A5048749599 @default.
- W4387675354 hasAuthorship W4387675354A5076626440 @default.
- W4387675354 hasBestOaLocation W43876753541 @default.
- W4387675354 hasConcept C120665830 @default.
- W4387675354 hasConcept C121332964 @default.
- W4387675354 hasConcept C121608353 @default.
- W4387675354 hasConcept C126322002 @default.
- W4387675354 hasConcept C142424586 @default.
- W4387675354 hasConcept C143998085 @default.
- W4387675354 hasConcept C197934379 @default.
- W4387675354 hasConcept C2777701055 @default.
- W4387675354 hasConcept C2780057760 @default.
- W4387675354 hasConcept C2781413609 @default.
- W4387675354 hasConcept C61511704 @default.
- W4387675354 hasConcept C71924100 @default.
- W4387675354 hasConcept C87355193 @default.
- W4387675354 hasConceptScore W4387675354C120665830 @default.
- W4387675354 hasConceptScore W4387675354C121332964 @default.
- W4387675354 hasConceptScore W4387675354C121608353 @default.
- W4387675354 hasConceptScore W4387675354C126322002 @default.
- W4387675354 hasConceptScore W4387675354C142424586 @default.
- W4387675354 hasConceptScore W4387675354C143998085 @default.
- W4387675354 hasConceptScore W4387675354C197934379 @default.
- W4387675354 hasConceptScore W4387675354C2777701055 @default.
- W4387675354 hasConceptScore W4387675354C2780057760 @default.
- W4387675354 hasConceptScore W4387675354C2781413609 @default.
- W4387675354 hasConceptScore W4387675354C61511704 @default.
- W4387675354 hasConceptScore W4387675354C71924100 @default.
- W4387675354 hasConceptScore W4387675354C87355193 @default.
- W4387675354 hasLocation W43876753541 @default.
- W4387675354 hasOpenAccess W4387675354 @default.
- W4387675354 hasPrimaryLocation W43876753541 @default.
- W4387675354 hasRelatedWork W2350203434 @default.
- W4387675354 hasRelatedWork W2517747645 @default.
- W4387675354 hasRelatedWork W2585407512 @default.
- W4387675354 hasRelatedWork W2767391212 @default.
- W4387675354 hasRelatedWork W2891524425 @default.
- W4387675354 hasRelatedWork W2945780494 @default.
- W4387675354 hasRelatedWork W3029425576 @default.
- W4387675354 hasRelatedWork W3037068108 @default.
- W4387675354 hasRelatedWork W3041652591 @default.
- W4387675354 hasRelatedWork W4200023723 @default.
- W4387675354 isParatext "false" @default.
- W4387675354 isRetracted "false" @default.
- W4387675354 workType "article" @default.